Author:
Shibata Shoyo,Uemura Ryotaro,Suzuki Takeshi
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference25 articles.
1. Danzon PM, Pauly MV. Health insurance and the growth in pharmaceutical expenditures. J Law Econ. 2002;45:587–613.
2. Morgan SG. Prescription drug expenditures and population demographics. Health Serv Res. 2006;41:411–428.
3. Kurosawa H, Tamura K. Japanese drug pricing system: how to balance innovation and the reimbursement system [in Japanese]. Nihon Yakurigaku Zasshi. 2012;139:260.
4. Ministry of Health, Labour and Welfare. Conceptual diagram of repricing for market expansion. http://www.mhlw.go.jp/stf/shingi/2r98520000020zbe-att/2r98520000020zy6.pdf. Published January 25, 2012. Accessed April 7, 2016.
5. Ministry of Health, Labour and Welfare. Requirements for repricing for market expansion. http://www.mhlw.go.jp/stf/shingi/2r9852000001tu6d-att/2r9852000001tupq.pdf. Published November 2, 2011. Accessed April 7, 2016.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献